A meta-analysis published in 2020 shows that L-carnitine supplementation for patients with non-alcoholic fatty liver disease demonstrates a reduction in AST, ALT, TG levels, and HOMA-IR [15]
Common GLP-1 medications include: Semaglutide (e.g
References: Jensen JK, Binderup T, Grandjean CE, Bentsen S, Ripa RS, Kjaer A
Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart Association
Layla aims to reply to any and all customer service-related matters within 24 hours, but we could not find a phone number for Layla, either for customer service or medical questions
Many patients discontinue treatment because they cannot tolerate the side effects of drugs, which leads to poor treatment efficacy